Cargando…

Chemoradiotherapy with FOLFOX for esophageal squamous cell cancer with synchronous rectal cancer: Four case reports and a literature review

Chemoradiotherapy (CRT) is a valuable treatment option for localized esophageal cancer. Conventional baseline chemotherapy for this type of cancer includes cisplatin and fluorouracil. Recently, CRT with leucovorin-fluorouracil-oxaliplatin (FOLFOX) has become popular due to its convenience and lower...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshii, Takako, Hara, Hiroki, Asayama, Masako, Kumekawa, Yosuke, Miyazawa, Shoichi, Takahashi, Naoki, Matsushima, Tomohiro, Shimizu, Satoshi, Saito, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888043/ https://www.ncbi.nlm.nih.gov/pubmed/31814973 http://dx.doi.org/10.3892/mco.2019.1945

Ejemplares similares

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer
por: Michael, M, et al.
Publicado: (2014)

Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
por: Li, Jing, et al.
Publicado: (2020)

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
por: Conroy, T, et al.
Publicado: (2010)

A complete response to mFOLFOX6 and panitumumab chemotherapy in advanced stage rectal adenocarcinoma: a case report
por: Sonoda, Hiromichi, et al.
Publicado: (2014)

Chemoradiotherapy response in recurrent rectal cancer
por: Yu, Stanley K T, et al.
Publicado: (2014)

An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2016)

A Rectal Metastasis from Renal Pelvic Cancer
por: Asayama, Naoki, et al.
Publicado: (2022)

Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer
por: Imano, Nobuki, et al.
Publicado: (2020)

Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Miyako, Shoji, et al.
Publicado: (2023)

Timing of surgery following chemoradiotherapy in rectal Cancer
por: Brown, Gina, et al.
Publicado: (2014)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Radiation boost for synchronous solitary inguinal lymph node metastasis during neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Chen, Mo, et al.
Publicado: (2021)

Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial)
por: Kang, Min Kyu, et al.
Publicado: (2023)

Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectives
por: Yamashita, Kimihiro, et al.
Publicado: (2018)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2011)

Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer
por: SHOJI, HISANORI, et al.
Publicado: (2016)

A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)

Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer
por: Wang, Shichao, et al.
Publicado: (2019)

Synchronous Breast and Rectal Cancers in a Man
por: Karayiannakis, Anastasios J., et al.
Publicado: (2011)

Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses
por: Shoji, Hisanori, et al.
Publicado: (2017)

Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer
por: Akiyoshi, Takashi, et al.
Publicado: (2023)

The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
por: Shimada, Atsushi, et al.
Publicado: (2023)

Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
por: Nakamura, Yuki, et al.
Publicado: (2018)

Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
por: Lee, Jii Bum, et al.
Publicado: (2020)

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer
por: De Felice, Francesca, et al.
Publicado: (2013)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer
por: Zhang, Jin-Liang, et al.
Publicado: (2017)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients
por: Yasui, Kazuaki, et al.
Publicado: (2020)

Predictive immunohistochemical features for tumour response to chemoradiotherapy in rectal cancer
por: Shinto, E., et al.
Publicado: (2020)

Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

Organ preservation for early rectal cancer using preoperative chemoradiotherapy
por: Son, Gyung Mo
Publicado: (2023)

Pathological complete response after preoperative chemotherapy including FOLFOX plus bevacizumab for locally advanced rectal cancer: A case report and literature review
por: Miyamoto, Ryoichi, et al.
Publicado: (2019)

Treatment with Corticosteroid for Pericardial Effusion in a Patient with Advanced Synchronous Esophageal and Gastric Cancers following Chemoradiotherapy
por: Osawa, Satoshi, et al.
Publicado: (2010)

Comparisons of Efficacy, Safety, and Cost of Chemotherapy Regimens FOLFOX4 and FOLFIRINOX in Rectal Cancer: A Randomized, Multicenter Study
por: Qi, Fei, et al.
Publicado: (2018)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
por: Tokuhara, Katsuji, et al.
Publicado: (2016)

Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rvmvhfi3lidkf3je9vieh5rc3